Xponance’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4M | Sell |
220,384
-1,576
| -0.7% | -$175K | 0.2% | 80 |
|
|
2025
Q1 | $24.9M | Buy |
221,960
+28,744
| +15% | +$3.22M | 0.24% | 65 |
|
|
2024
Q4 | $17.8M | Sell |
193,216
-736
| -0.4% | -$68K | 0.16% | 99 |
|
|
2024
Q3 | $16.3M | Sell |
193,952
-989
| -0.5% | -$82.9K | 0.16% | 104 |
|
|
2024
Q2 | $13.4M | Sell |
194,941
-1,000
| -0.5% | -$68.6K | 0.14% | 118 |
|
|
2024
Q1 | $14.4M | Buy |
195,941
+9,498
| +5% | +$696K | 0.15% | 118 |
|
|
2023
Q4 | $15.1M | Buy |
186,443
+13,667
| +8% | +$1.11M | 0.18% | 99 |
|
|
2023
Q3 | $12.9M | Buy |
172,776
+1,662
| +1% | +$125K | 0.18% | 94 |
|
|
2023
Q2 | $13.2M | Sell |
171,114
-1,241
| -0.7% | -$95.6K | 0.18% | 99 |
|
|
2023
Q1 | $14.3M | Buy |
172,355
+3,650
| +2% | +$303K | 0.21% | 90 |
|
|
2022
Q4 | $14.5M | Buy |
168,705
+19,312
| +13% | +$1.66M | 0.23% | 83 |
|
|
2022
Q3 | $9.22M | Buy |
149,393
+39,581
| +36% | +$2.44M | 0.18% | 109 |
|
|
2022
Q2 | $6.79M | Buy |
109,812
+19,081
| +21% | +$1.18M | 0.14% | 132 |
|
|
2022
Q1 | $5.39M | Buy |
90,731
+4,485
| +5% | +$267K | 0.09% | 187 |
|
|
2021
Q4 | $6.26M | Buy |
86,246
+19,343
| +29% | +$1.4M | 0.1% | 178 |
|
|
2021
Q3 | $4.67M | Sell |
66,903
-6,062
| -8% | -$423K | 0.09% | 190 |
|
|
2021
Q2 | $5.02M | Sell |
72,965
-36,147
| -33% | -$2.49M | 0.09% | 179 |
|
|
2021
Q1 | $7.05M | Buy |
109,112
+597
| +0.6% | +$38.6K | 0.15% | 127 |
|
|
2020
Q4 | $6.32M | Buy |
108,515
+953
| +0.9% | +$55.5K | 0.14% | 131 |
|
|
2020
Q3 | $6.8M | Sell |
107,562
-11,846
| -10% | -$749K | 0.17% | 111 |
|
|
2020
Q2 | $9.19M | Buy |
+119,408
| New | +$9.19M | 0.24% | 90 |
|